Haemonetics Corp. (HAE)
122.94
+0.23
(+0.19%)
USD |
NYSE |
Nov 13, 16:00
122.90
-0.04
(-0.03%)
Pre-Market: 19:59
Haemonetics Net Income (Quarterly) : 46.30M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 46.30M |
| June 30, 2026 | 33.01M |
| March 31, 2026 | -20.15M |
| December 31, 2025 | 44.74M |
| September 30, 2025 | 38.68M |
| June 30, 2025 | 34.03M |
| March 31, 2025 | 57.98M |
| December 31, 2024 | 37.49M |
| September 30, 2024 | 33.83M |
| June 30, 2024 | 38.37M |
| March 31, 2024 | 20.37M |
| December 31, 2023 | 31.24M |
| September 30, 2023 | 24.91M |
| June 30, 2023 | 41.04M |
| March 31, 2023 | 29.38M |
| December 31, 2022 | 32.94M |
| September 30, 2022 | 33.20M |
| June 30, 2022 | 19.88M |
| March 31, 2022 | 9.741M |
| December 31, 2021 | 23.23M |
| September 30, 2021 | 14.86M |
| June 30, 2021 | -4.454M |
| March 31, 2021 | -11.04M |
| December 31, 2020 | 31.88M |
| September 30, 2020 | 48.10M |
| Date | Value |
|---|---|
| June 30, 2020 | 10.53M |
| March 31, 2020 | 17.62M |
| December 31, 2019 | 29.90M |
| September 30, 2019 | 37.49M |
| June 30, 2019 | -8.479M |
| March 31, 2019 | 20.84M |
| December 31, 2018 | 18.28M |
| September 30, 2018 | 18.73M |
| June 30, 2018 | -2.819M |
| March 31, 2018 | 11.88M |
| December 31, 2017 | -6.547M |
| September 30, 2017 | 20.10M |
| June 30, 2017 | 20.14M |
| March 31, 2017 | -51.14M |
| December 31, 2016 | 15.39M |
| September 30, 2016 | 19.82M |
| June 30, 2016 | -10.35M |
| March 31, 2016 | -8.776M |
| December 31, 2015 | -59.44M |
| September 30, 2015 | 12.86M |
| June 30, 2015 | -0.267M |
| March 31, 2015 | -2.93M |
| December 31, 2014 | 15.99M |
| September 30, 2014 | 7.487M |
| June 30, 2014 | -3.649M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 141.17M |
| Abbott Laboratories | 920.00M |
| ICU Medical, Inc. | 26.85M |
| Merit Medical Systems, Inc. | 42.31M |
| Teleflex, Inc. | 54.29M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 357.76M |
| Total Expenses (Quarterly) | 311.45M |
| EPS Diluted (Quarterly) | 0.9966 |
| Enterprise Value | 6.460B |
| Gross Profit Margin (Quarterly) | 58.78% |
| Profit Margin (Quarterly) | 12.94% |
| Earnings Yield | 1.82% |
| Operating Earnings Yield | 4.49% |
| Normalized Earnings Yield | 2.766 |